COVID-19 vaccination in Djibouti is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.


Djibouti began its vaccination program on 15 March 2021, initially with 24,000 doses of AstraZeneca's Covishield vaccine provided through COVAX

History

Timeline

March 2021
By the end of the month 455 vaccine doses had been administered

April 2021
By the end of the month 11,343 vaccine doses had been administered

May 2021
By the end of the month 14,943 vaccine doses had been administered

June 2021
By the end of the month 35,606 vaccine doses had been administered

August 2021
By the end of the month 54,229 vaccine doses had been administered

September 2021
By the end of the month 67,229 vaccine doses had been administered

October 2021
By the end of the month 92,097 vaccine doses had been administered while 7% of the targeted population had been fully vaccinated

November 2021
By the end of the month 99,679 vaccine doses had been administered while 7% of the targeted population had been fully vaccinated

December 2021
By the end of the month 200,309 vaccine doses had been administered while 23% of the targeted population had been fully vaccinated

January 2022
By the end of the month 213,820 vaccine doses had been administered while 25% of the targeted population had been fully vaccinated

Progress 
Cumulative vaccinations in Djibouti

References 

Djibouti
Vaccination
Djibouti